Cargando…
Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re‐evaluation of an established drug
Several noncardiac drugs have been linked to cardiac safety concerns, highlighting the importance of post‐marketing surveillance and continued evaluation of the benefit‐risk of long‐established drugs. Here, we examine the risk of QT prolongation and/or torsade de pointes (TdP) associated with the us...
Autores principales: | Schlit, Anne‐Françoise, Delaunois, Annie, Colomar, Aurore, Claudio, Branderley, Cariolato, Luca, Boev, Rossen, Valentin, Jean‐Pierre, Peters, Christopher, Sloan, Victor S., Bentz, Jürgen W. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415947/ https://www.ncbi.nlm.nih.gov/pubmed/28480041 http://dx.doi.org/10.1002/prp2.309 |
Ejemplares similares
-
DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999) -
QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015) -
Hydroxyzine-induced Torsade de Pointes in a Patient with Complete Atrioventricular Block
por: Koshino, Kaito, et al.
Publicado: (2021) -
Hydroxyzine-Induced Torsade De Pointes: A Case Report and a Literature Review
por: Afzal, Muhammad Adil, et al.
Publicado: (2023) -
QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)